Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.
Elias Zerhouni has joined the Gates Foundation, Aushon Biosystems has named a new VP of North American Sales, Joshua LaBaer heads West to Arizona State University, and more.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.